SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,638 | -75.7% | 24,405 | -47.4% | 0.00% | – |
| Q2 2023 | $60,330 | +179.8% | 46,408 | +278.8% | 0.00% | – |
| Q1 2023 | $21,561 | -26.9% | 12,251 | +30.5% | 0.00% | – |
| Q4 2022 | $29,481 | -41.0% | 9,389 | -8.0% | 0.00% | – |
| Q3 2022 | $50,000 | +56.2% | 10,205 | +31.5% | 0.00% | – |
| Q2 2022 | $32,000 | -93.0% | 7,760 | -90.1% | 0.00% | -100.0% |
| Q1 2022 | $457,000 | -37.7% | 78,705 | -19.5% | 0.00% | 0.0% |
| Q4 2021 | $733,000 | – | 97,778 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,032,980 | $12,950,000 | 1.82% |
| EcoR1 Capital, LLC | 2,308,079 | $14,702,000 | 1.54% |
| Alexandria Capital, LLC | 1,005,119 | $6,403,000 | 1.05% |
| Casdin Capital, LLC | 1,455,000 | $9,268,000 | 0.98% |
| Rhenman & Partners Asset Management AB | 700,000 | $4,459,000 | 0.62% |
| Bellevue Group AG | 3,850,000 | $24,525,000 | 0.48% |
| GREAT POINT PARTNERS LLC | 633,505 | $4,035,000 | 0.42% |
| WASATCH ADVISORS LP | 5,938,434 | $37,828,000 | 0.39% |
| 361 CAPITAL LLC | 109,161 | $695,000 | 0.32% |
| Ceeto Capital Group, LLC | 50,000 | $319,000 | 0.26% |